{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:01:48Z","timestamp":1792785708993,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011102","name":"European Union's Health Programme","doi-asserted-by":"publisher","award":["724161"],"award-info":[{"award-number":["724161"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Consumers, Health, Agricolture and Food Executive Agency (Chafea)","award":["2000111201"],"award-info":[{"award-number":["2000111201"]}],"id":[{"id":"https:\/\/ror.org\/02578qw11","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ejca.2018.12.031","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T04:51:04Z","timestamp":1550551864000},"page":"120-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"special_numbering":"C","title":["Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers\u00a0in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors"],"prefix":"10.1016","volume":"110","author":[{"given":"Andrea","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines B.","family":"Brecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Gatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik T.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Orbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Cecchetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Godzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Reguerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Bien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Stachowicz-Stencel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Magni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Vassal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Massimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Bisogno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8220-9833","authenticated-orcid":false,"given":"Annalisa","family":"Trama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ejca.2018.12.031_bib1","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.ejca.2011.08.008","article-title":"Rare cancers are not so rare: the rare cancer burden in Europe","volume":"47","author":"Gatta","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2018.12.031_bib2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ejca.2006.08.028","article-title":"The challenge of very rare tumours in childhood: the Italian TREP project","volume":"43","author":"Ferrari","year":"2007","journal-title":"Eur J Cancer"},{"issue":"16","key":"10.1016\/j.ejca.2018.12.031_bib3","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1002\/cncr.28745","article-title":"Declining childhood and adolescent cancer mortality: great progress but still much to be done","volume":"120","author":"Pritchard-Jones","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2018.12.031_bib4","doi-asserted-by":"crossref","unstructured":"Ferrari A, Schneider DT, Bisogno G, Orbach D, Villarroel M, Giron V, et al. The challenge of very rare childhood cancer in developed and developing countries. Expert Opin Orphan Drugs. https:\/\/doi.org\/10.1080\/21678707.2017.1298440.","DOI":"10.1080\/21678707.2017.1298440"},{"issue":"27","key":"10.1016\/j.ejca.2018.12.031_bib5","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1200\/JCO.2014.59.3632","article-title":"Rare tumors in children: progress through collaboration","volume":"33","author":"Pappo","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2018.12.031_bib6","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/pbc.24997","article-title":"Rare malignant pediatric tumors registered in the German Childhood Cancer Registry 2001-2010","volume":"61","author":"Brecht","year":"2014","journal-title":"Pediatr Blood Canc"},{"issue":"Suppl 2","key":"10.1016\/j.ejca.2018.12.031_bib7","first-page":"57","article-title":"Rare tumours - are they really rare in the Polish children population?","volume":"61","author":"Balcerska","year":"2004","journal-title":"Przegl Lek"},{"issue":"9","key":"10.1016\/j.ejca.2018.12.031_bib8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1684\/bdc.2010.1169","article-title":"Epidemiology and management of rare paediatric tumours within the framework of the French Society for Children Cancer","volume":"97","author":"R\u00e9guerre","year":"2010","journal-title":"Bull Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2018.12.031_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/era.12.155","article-title":"EXPeRT board. The founding of the European cooperative study group on pediatric rare tumors - EXPeRT","volume":"13","author":"Ferrari","year":"2013","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ejca.2018.12.031_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejca.2015.09.023","article-title":"The Children's Hepatic tumors International Collaboration (CHIC) novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model","volume":"52","author":"Czauderna","year":"2016","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2018.12.031_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26348","article-title":"Access to clinical trials for adolescents with soft tissue sarcomas: enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols","volume":"64","author":"Ferrari","year":"2017","journal-title":"Pediatr Blood Canc"},{"key":"10.1016\/j.ejca.2018.12.031_bib12","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1200\/JCO.2010.31.2603","article-title":"Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plans","volume":"28","author":"Pappo","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2018.12.031_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1470-2045(18)30105-0","article-title":"10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers","volume":"19","author":"Pearson","year":"2018","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2018.12.031_bib14","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1586\/era.10.96","article-title":"Selecting multimodal therapy for rhabdomyosarcoma","volume":"10","author":"Sultan","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"10.1016\/j.ejca.2018.12.031_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejca.2013.08.015","article-title":"Treatment and prognostic factors in pleuropulmonary blastoma: an EXPeRT report","volume":"50","author":"Bisogno","year":"2014","journal-title":"Eur J Cancer"},{"issue":"15","key":"10.1016\/j.ejca.2018.12.031_bib16","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.ejca.2011.05.022","article-title":"Pancreatoblastoma: a report from the European cooperative study group for paediatric rare tumours (EXPeRT)","volume":"47","author":"Bien","year":"2011","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2018.12.031_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26947","article-title":"BRIM-P: a phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanoma","volume":"65","author":"Chisholm","year":"2018","journal-title":"Pediatr Blood Canc"},{"key":"10.1016\/j.ejca.2018.12.031_bib18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ejca.2017.09.032","article-title":"Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma","volume":"86","author":"Geoerger","year":"2017","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2018.12.031_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26974","article-title":"Pediatric patients with cutaneous melanoma: a European study","volume":"65","author":"Brecht","year":"2018","journal-title":"Pediatr Blood Canc"},{"issue":"8","key":"10.1016\/j.ejca.2018.12.031_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27025","article-title":"Thyroid cancer in adolescents and young adults","volume":"65","author":"Massimino","year":"2018","journal-title":"Pediatr Blood Canc"},{"issue":"5","key":"10.1016\/j.ejca.2018.12.031_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamapediatrics.2015.4689","article-title":"Cancer in adolescents and young adults: a narrative review of the current status and a view of the future","volume":"170","author":"Barr","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"8","key":"10.1016\/j.ejca.2018.12.031_bib22","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1470-2045(17)30445-X","article-title":"Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study","volume":"18","author":"Gatta","year":"2017","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2018.12.031_bib23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","article-title":"International incidence of childhood cancer, 2001\u201310: a population-based registry study","volume":"18","author":"Steliarova-Foucher","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2018.12.031_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canep.2018.04.003","article-title":"Bayesian estimates of incidence rates and number of cases by country for rare cancers in Europe","volume":"54","author":"Botta","year":"2018","journal-title":"Cancer Epidemiol"},{"issue":"7","key":"10.1016\/j.ejca.2018.12.031_bib25","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S1470-2045(17)30243-7","article-title":"Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study","volume":"18","author":"Schwalbe","year":"2017","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2018.12.031_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-016-1643-0","article-title":"The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants","volume":"133","author":"Pajtler","year":"2017","journal-title":"Acta Neuropathol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919300097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919300097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T20:20:57Z","timestamp":1754684457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804919300097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":26,"alternative-id":["S0959804919300097"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2018.12.031","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers\u00a0in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2018.12.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}